MDH2 and neoplasm: In this study, we integrated data from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Human Protein Atlas (HPA), Tumor Immune Estimation Resource (TIMER), transcriptomics, and metabolomics to identify MDH2 as a key metabolic enzyme in BRCA progression.